Thermo Fisher Scientific Inc. (NYSE:TMO)

An analysis of valuation ratios between April 2022 and June 2026 reveals a distinct cyclical pattern characterized by an expansion phase through mid-2024, a significant contraction period in early 2025, and a subsequent partial recovery through mid-2026. All four primary valuation metrics—Price to Earnings, Price to Operating Profit, Price to Sales, and Price to Book Value—demonstrate a high degree of positive correlation, moving in tandem across the observed period.

Earnings and Profitability Multiples

The Price to Earnings (P/E) ratio exhibited considerable volatility, rising from 28.15 in April 2022 to a peak of 37.81 in June 2024. This expansion suggests an increase in investor willingness to pay a premium for earnings during this window. However, a sharp correction occurred by March 2025, where the P/E ratio fell to its lowest point of 24.55, before rebounding to 30.48 by June 2026. Similarly, the Price to Operating Profit (P/OP) ratio peaked in June 2024 at 32.66 and reached a trough in March 2025 at 21.64, mirroring the trajectory of the P/E ratio and confirming a synchronized shift in profit-based valuation.

Sales and Asset-Based Multiples

The Price to Sales (P/S) and Price to Book Value (P/BV) ratios followed a comparable trend of expansion and contraction. The P/S ratio reached its maximum of 5.55 in June 2024 before declining to a low of 3.73 in March 2025. The P/BV ratio similarly peaked early in the period at 5.47 in July 2022 and hit a minimum of 3.24 in March 2025. Both metrics showed a moderate recovery by June 2026, with P/S ending at 4.58 and P/BV at 4.03.

Comparative Valuation Trends

The most pronounced valuation compression occurred between June 2024 and March 2025, where all ratios experienced a simultaneous decline. This suggests a period of systemic de-rating. The recovery phase from March 2025 to June 2026 was characterized by a gradual return toward historical means, though the ratios remained generally lower than the peaks observed in 2023 and early 2024. The consistency across all four ratios indicates that the valuation shifts were driven by changes in market sentiment or stock price movements rather than isolated changes in a single financial metric.

Analysis of the financial valuation metrics indicates a period of significant volatility in the Price to Earnings (P/E) ratio, driven by divergent movements between share price and earnings per share (EPS) over the observed timeframe.

Earnings per Share (EPS) Performance

A distinct U-shaped trajectory is observed in earnings per share. EPS declined from 19.42 in April 2022 to a period low of 14.82 in July 2023. Following this trough, a consistent recovery phase began, with earnings steadily increasing through 2024 and 2025, eventually reaching 18.84 by June 2026.

P/E Ratio Expansion and Contraction

The P/E ratio underwent a period of significant expansion throughout 2023 and early 2024, peaking at 37.81 in June 2024. This indicated a period where market valuation grew faster than actual earnings. This was followed by a sharp contraction in valuation, with the ratio dropping to a low of 24.55 in March 2025, before rebounding to 30.48 by mid-2026.

Share Price Influence on Valuation

The volatility in the P/E ratio is primarily attributed to share price fluctuations rather than earnings stability. The peak valuation in June 2024 coincided with the highest share price of 615.69. Conversely, the valuation trough in March 2025 occurred during a share price low of 423.55, occurring even as EPS continued its upward trend, suggesting a temporary decoupling of market price from earnings growth during that period.

The Price to Operating Profit (P/OP) ratio demonstrates significant volatility over the analyzed period, characterized by a distinct phase of valuation expansion followed by a correction and a subsequent period of stabilization.

Operating Profit Trajectory

Operating profit per share exhibited a downward trend throughout 2022 and early 2023, falling from a peak of $25.03 in April 2022 to a low of $17.39 in July 2023. Following this trough, a consistent recovery phase is observed, with operating profits steadily increasing from March 2024 through June 2026, eventually reaching $22.03 per share.

P/OP Ratio Expansion

A significant increase in the P/OP ratio occurred between April 2023 and June 2024. During this window, the ratio climbed from 29.54 to a peak of 32.66. This expansion indicates that the market maintained a higher valuation premium despite the contraction in operating profits per share during the preceding year.

Valuation Correction and Stabilization

A sharp contraction in the valuation multiple is evident in the second half of 2024, with the P/OP ratio declining from 32.66 in June to 21.64 by December 31, 2024. This represents a realignment of the share price with operating performance. From 2025 through mid-2026, the ratio entered a period of fluctuation between 22.09 and 28.40, suggesting a normalization of the valuation range.

Correlation Between Price and Profit

The data reveals that the peak P/OP ratios were driven by a combination of stagnant or declining operating profits and a resilient share price. The subsequent decline in the ratio by late 2024 was influenced by a notable drop in share price to $537.83 and $537.83 before hitting $423.55 in March 2025, which coincided with the beginning of the operating profit recovery.

The valuation of the common stock, as measured by the Price-to-Sales (P/S) ratio, demonstrates significant volatility over the period from April 2022 to June 2026. While sales per share exhibit a gradual and consistent upward trajectory, the P/S ratio fluctuates primarily in response to substantial changes in the market share price.

Sales per Share Performance

A steady growth pattern is observed in sales per share, which increased from 105.05 US$ in April 2022 to 125.32 US$ by June 2026. This long-term increase indicates a consistent expansion of revenue generation per share, providing a stable fundamental baseline despite market price fluctuations.

Price-to-Sales Ratio Volatility

The P/S ratio experienced several peaks and troughs, reaching a maximum of 5.55 in June 2024 and a minimum of 3.73 in March 2025. The sharp contraction observed in early 2025 correlates with a decline in the share price to 423.55 US$, indicating a period where the market valuation compressed significantly relative to the underlying sales performance.

Valuation Recovery and Correlation

Following the trough in March 2025, a recovery trend is evident, with the P/S ratio ascending to 4.58 by June 2026. This recovery was driven by a rebound in the share price to 574.30 US$. The divergence between the steady rise in sales per share and the erratic movement of the P/S ratio suggests that the valuation multiple is more heavily influenced by broader market sentiment and equity pricing than by incremental changes in sales efficiency.

An analysis of the valuation metrics from April 2022 through June 2026 reveals a general compression in the Price to Book Value (P/BV) ratio. While the ratio began the period at 5.23 and peaked at 5.47 in July 2022, it concluded at 4.03 in June 2026, indicating a shift in how the market values the company's equity relative to its book value.

Book Value per Share (BVPS) Trend

A consistent upward trajectory in Book Value per Share is observed, rising from 104.62 USD in April 2022 to 142.47 USD by June 2026. This steady growth suggests a strengthening of the company's underlying equity base over the analyzed period, despite occasional minor fluctuations, such as the dip to 109.55 USD in April 2023.

Price to Book Value (P/BV) Volatility

The P/BV ratio exhibited significant volatility, closely mirroring fluctuations in the share price. Notable contractions occurred in September 2023, where the ratio fell to 3.88, and reached a period low of 3.24 in March 2025. These declines were primarily driven by share price depreciation that outpaced the growth in book value.

Valuation Dynamics

A divergence is evident between the steady growth of BVPS and the more erratic movement of the share price. The reduction in the P/BV ratio from the 5.0x range in 2022 to the 3.0x-4.0x range in 2025 and 2026 suggests a market repricing or a decrease in the premium investors are willing to pay per unit of book value.

Recent Recovery Patterns

Following the low point in March 2025, the P/BV ratio showed signs of recovery, climbing to 4.18 in June 2025 before stabilizing around 4.03 by June 2026. This indicates a partial return of valuation premiums despite the continued increase in the denominator (BVPS).